Rapid Developability Assessment of Early Phase Molecules: Parallel Screening of Enabling Technologies and Use of PBPK Modeling
Summary: Achieving success in early development is essential in progressing to your molecule’s next milestone. While solving solubility is a major hurdle to overcome in early development, there are additional biopharmaceutical challenges to consider on the path to commercialization. This webinar will demonstrate how additional screening strategies can help you better understand your molecule and predict its future success on the path to commercialization.
Experts will share a recent case study that illustrates how to use PBPK modeling, the developability classification system¹ and the biopharmaceutics drug distribution classification system² together to facilitate the development of a molecule.